These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 2596471

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Differences between membranoproliferative glomerulonephritis types I and III in long-term response to an alternate-day prednisone regimen.
    Braun MC, West CD, Strife CF.
    Am J Kidney Dis; 1999 Dec; 34(6):1022-32. PubMed ID: 10585311
    [Abstract] [Full Text] [Related]

  • 24. Effects of combined immunosuppressive, anticoagulant and antiaggregant treatment on the course of chronic membranoproliferative glomerulonephritis.
    Dimitrakov D, Simeonov S, Despotov T, Kumchev E, Tsvetkova Z.
    Folia Med (Plovdiv); 1991 Dec; 33(4):36-9. PubMed ID: 1669040
    [No Abstract] [Full Text] [Related]

  • 25. Severe recurrence of type I membranoproliferative glomerulonephritis after transplantation: remission on steroids and cyclophosphamide.
    Cahen R, Trolliet P, Dijoud F, Megri K, François B.
    Transplant Proc; 1995 Apr; 27(2):1746-7. PubMed ID: 7725484
    [No Abstract] [Full Text] [Related]

  • 26. Long-term follow-up of non-systemic lupus erythematosus glomerulonephritis in patients with hereditary angioedema: report of four cases.
    Pan CG, Strife CF, Ward MK, Spitzer RE, McAdams AJ.
    Am J Kidney Dis; 1992 Jun; 19(6):526-31. PubMed ID: 1595700
    [Abstract] [Full Text] [Related]

  • 27. A case of IgA nephritis showing diffuse podocytic detachment from the glomerular basement membrane.
    Moriya T, Nakazawa K, Itoh N, Shigematsu H, Higuchi M, Miyasaka M, Oguchi H.
    Nihon Jinzo Gakkai Shi; 1992 Apr; 34(4):423-30. PubMed ID: 1635288
    [Abstract] [Full Text] [Related]

  • 28. [Primary chronic glomerulonephritis with nephrotic syndrome. Treatment with prednisone and cyclophosphamide].
    Knotková V, Nĕmecek K, Tarayeva IE, Krasnova TN.
    Vnitr Lek; 1993 Dec; 39(12):1157-63. PubMed ID: 8310664
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Successful cyclophosphamide treatment of cryoglobulinemic membranoproliferative glomerulonephritis associated with hepatitis C virus infection.
    Quigg RJ, Brathwaite M, Gardner DF, Gretch DR, Ruddy S.
    Am J Kidney Dis; 1995 May; 25(5):798-800. PubMed ID: 7747735
    [Abstract] [Full Text] [Related]

  • 31. Effect of combined immunosuppressive anticoagulant and antiplatelet therapy of the course of chronic mesangial-proliferative glomerulonephritis.
    Matousovic K, Matl I, Zabka J, Zástava V, Rossmann P, Prát V.
    Czech Med; 1985 May; 8(3):151-7. PubMed ID: 3932033
    [Abstract] [Full Text] [Related]

  • 32. [Programs of immunosuppressive and anti-inflammatory therapy of primary idiopathic glomerulonephritis. II. Membranous, membrano- proliferative and mesangial glomerulonephritis].
    Klinger M, Szewczyk Z.
    Przegl Lek; 1989 May; 46(12):816-21. PubMed ID: 2698488
    [No Abstract] [Full Text] [Related]

  • 33. Long-term follow-up of type II membranoproliferative glomerulonephritis in two children.
    Iitaka K, Nakamura S, Moriya S, Koshino H, Iwasaki N, Motoyama O, Sakai T.
    Clin Exp Nephrol; 2003 Mar; 7(1):58-62. PubMed ID: 14586745
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Poststreptococcal crescenteric glomerulonephritis in children: comparison of quintuple therapy versus supportive care.
    Roy S, Murphy WM, Arant BS.
    J Pediatr; 1981 Mar; 98(3):403-10. PubMed ID: 7205449
    [Abstract] [Full Text] [Related]

  • 36. Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole.
    Chesebro JH, Fuster V, Elveback LR, McGoon DC, Pluth JR, Puga FJ, Wallace RB, Danielson GK, Orszulak TA, Piehler JM, Schaff HV.
    Am J Cardiol; 1983 May 15; 51(9):1537-41. PubMed ID: 6342354
    [Abstract] [Full Text] [Related]

  • 37. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL, Algra A, van Gijn J.
    Cochrane Database Syst Rev; 2003 May 15; (1):CD001820. PubMed ID: 12535415
    [Abstract] [Full Text] [Related]

  • 38. [The effect of treatment on the survival rate in chronic glomerulonephritis].
    Belovezhdov N, Robeva R, Dimitrova V.
    Vutr Boles; 1990 May 15; 29(6):29-35. PubMed ID: 2091380
    [Abstract] [Full Text] [Related]

  • 39. The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin: a two-year prospective trial.
    Walker RG, Yu SH, Owen JE, Kincaid-Smith P.
    Clin Nephrol; 1990 Sep 15; 34(3):103-7. PubMed ID: 2225560
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.